JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202755200 on September 30, 2002

J. Biol. Chem., Vol. 277, Issue 51, 49888-49895, December 20, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/51/49888    most recent
M202755200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dell, E. J.
Right arrow Articles by Hamm, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dell, E. J.
Right arrow Articles by Hamm, H. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The beta gamma Subunit of Heterotrimeric G Proteins Interacts with RACK1 and Two Other WD Repeat Proteins*

Edward J. DellDagger , Jennifer ConnorDagger , Songhai Chen§, Elizabeth G. Stebbins, Nikolai P. SkibaDagger , Daria Mochly-Rosen, and Heidi E. HammDagger §||

From the Dagger  Institute for Neuroscience and Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60613, the  Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5174, and the § Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600

Received for publication, March 21, 2002, and in revised form, September 26, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A yeast two-hybrid approach was used to discern possible new effectors for the beta gamma subunit of heterotrimeric G proteins. Three of the clones isolated are structurally similar to Gbeta , each exhibiting the WD40 repeat motif. Two of these proteins, the receptor for activated C kinase 1 (RACK1) and the dynein intermediate chain, co-immunoprecipitate with Gbeta gamma using an anti-Gbeta antibody. The third protein, AAH20044, has no known function; however, sequence analysis indicates that it is a WD40 repeat protein. Further investigation with RACK1 shows that it not only interacts with Gbeta 1gamma 1 but also unexpectedly with the transducin heterotrimer Galpha tbeta 1gamma 1. Galpha t alone does not interact, but it must contribute to the interaction because the apparent EC50 value of RACK1 for Galpha tbeta 1gamma 1 is 3-fold greater than that for Gbeta 1gamma 1 (0.1 versus 0.3 µM). RACK1 is a scaffold that interacts with several proteins, among which are activated beta IIPKC and dynamin-1 (1). beta IIPKC and dynamin-1 compete with Gbeta 1gamma 1 and Galpha tbeta 1gamma 1 for interaction with RACK1. These findings have several implications: 1) that WD40 repeat proteins may interact with each other; 2) that Gbeta gamma interacts differently with RACK1 than with its other known effectors; and/or 3) that the G protein-RACK1 complex may constitute a signaling scaffold important for intracellular responses.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Heterotrimeric G proteins are a family of proteins that transduce an extracellular signal to an intracellular response via a seven helical transmembrane G protein-coupled receptor (GPCR).1 Upon activation, the receptor facilitates the exchange of GDP for GTP in the Galpha subunit. Galpha is then thought to dissociate from the Gbeta gamma heterodimer allowing both complexes to individually activate a number of effectors (2, 3). Free Gbeta gamma interacts with a large assortment of effector proteins, including phospholipases (4), adenylyl cyclases (5), ion channels (6), and G protein-coupled receptor kinases (7). There are, however, G protein-coupled receptor responses, such as MAP kinase activation (8-10), receptor internalization (11, 12), and organelle transport (13-15) that are mediated through the Gbeta gamma subunit but that have not been definitively linked to known Gbeta gamma effectors.

Gbeta is the prototypical member of a family of proteins known as WD40 repeat proteins, which seem to function as adaptors and enzyme regulators (16, 17). Gbeta is the only WD40 repeat protein whose three-dimensional structure is known, and it exhibits a toroidal bladed beta -propeller structure, with each blade consisting of 4 anti-parallel beta -strands (18). Because the WD repeat motif is a structural element of the beta -propeller, all of these proteins are thought to be beta -propeller proteins with a variable number of blades. Furthermore, Gbeta subunits are known to interact with Ggamma subunits, proteins containing a Ggamma -like domain (19), a pleckstrin homology domain (20), a QXXER domain (found in adenylyl cyclases) (21), and a domain contained within phosducin and its relatives (22). In this work we propose that Gbeta gamma also interacts with certain other WD40 repeat proteins.

The dynein intermediate chain (DIC) is a WD40 repeat protein that is part of the cytoplasmic dynein multimeric protein complex, which consists of heavy, intermediate, light intermediate, and light chains (23). Dynein is a retrograde microtubule motor protein that is involved in cell division and in intracellular transport (24-26). The involvement of dynein in these processes is dictated by its different subunit composition (27) and by its interaction with another multimeric protein complex, dynactin (28-30). This latter interaction occurs through the intermediate chain of the dynein complex and through p150-glued of the dynactin complex (28, 31, 32). The regulation of the interaction between dynein and dynactin is not fully understood; however, phosphorylation plays a part (33-35).

The RACKs are also WD40 repeat proteins that were originally found by their ability to bind and to localize activated PKC (36, 37). Different RACKs interact with different PKC isozymes, and RACK1 interacts with beta IIPKC (38, 39). More recently, RACK1 has been shown to interact with a variety of other proteins such as dynamin-1 (40), Src (41, 42), the beta  subunit of integrins (43, 44), p120GAP (45), PDE4D5 (46, 47), the interferon-alpha receptor (48), the beta -chain of interleukin-5 receptor (49), and PTPµ (50) with some of these interactions being mutually exclusive and some being concurrent. RACK1 is now considered a scaffolding protein that allows specific multiprotein complexes to form during different signaling events. Interestingly, four of these proteins, PKC (51-54), dynamin-1 (11, 55), Src (9, 10), and integrins (56), have also been linked to G protein signaling.

In this study, we used a yeast two-hybrid screen to find new Gbeta gamma -interacting proteins and have isolated three proteins with the WD40 motif: RACK1, DIC, and an unknown protein, AAH20044. We confirmed the interaction of Gbeta gamma with RACK1 and DIC through co-immunoprecipitation using an anti-Gbeta 1 antibody. Further investigation with a GST-RACK1 fusion protein and purified retinal G proteins revealed that RACK1 not only interacts with Gbeta 1gamma 1 alone but also binds with an apparent higher affinity to the heterotrimer Galpha tbeta 1gamma 1. Galpha t alone does not bind to GST-RACK1, suggesting that the interaction is mainly through Gbeta gamma . This result was surprising because very few proteins other than receptors are known to interact with the whole heterotrimer, and most known effectors of Gbeta gamma bind at its Galpha -interacting face (57, 58). Mutational analysis of RACK1 shows that G proteins may bind to multiple regions, including one of the beta IIPKC-binding sites. Confirming this, Gbeta 1gamma 1 and Galpha tbeta 1gamma 1 compete with the binding of activated beta IIPKC to RACK1. Finally, Gbeta 1gamma 1, RACK1, and dynamin-1 do not form a trimeric complex, and dynamin-1 competes with the binding of Gbeta 1gamma 1 or Galpha tbeta 1gamma 1 to RACK1.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Recombinant dyamin-1 baculovirus was a gift from Dr. Sandra Schmid (Scripps Institute), and pET-His-DIC1A was a gift from Dr. Kevin Vaughan (University of Notre Dame). NIH3T3 cells were obtained from American Type Culture Collection. Transducin heterotrimer and individual alpha  and beta gamma subunits were purified from bovine retina as described (59).

Yeast Two-hybrid-- The Hybrid Hunter Two-hybrid System (Invitrogen) and Matchmaker LexA Two-hybrid System (Clontech, PT3040-1) were employed. The cloning of cDNAs into vectors was done by standard molecular techniques. cDNA corresponding to bovine beta 1 was cloned into pLexA using EcoRI/XhoI sites, and the mouse brain library (Clontech) was cloned into pB42AD using EcoRI/XhoI sites. By using the EcoRI/XhoI sites, bovine gamma 2 was cloned into pHybLexA/Zeo. The LexA BD (binding domain) of this plasmid was deleted beforehand by incorporating an EcoRI site upstream of the BD (Quick Change Mutation, Stratagene), referred to now as pHyb. The yeast strain EGY48/pSH18-34, which has a LEU2 site integrated in the genome and a lacZ plasmid, was employed. Transformation of the yeast was performed as outlined in the Matchmaker LexA Two-hybrid System User's Manual. Interaction of the proteins was determined by the ability of the yeast to grow on leucine minus (leu-) media and the ability to turn blue in the presence of 5-bromo-4-chloro-3-indolyl beta -D-galactopyranoside (X-gal). The "positive" clones were sequenced, and a BLASTN search was performed to determine the identity of the proteins (74).

Expression and Purification of Cytoplasmic Dynein Intermediate Chain-1A-- A 10-ml LB/amp(100 µg/ml) overnight culture of Escherichia coli BL21 cells containing pET-DIC1A was used to inoculate 500 ml of 2YT/amp. The culture was grown for 2.5 h (A600 = 0.6) at 37 °C and then induced with isopropylthio-beta -galactoside (IPTG) (0.5 mM) for 4 h. Cells were collected and frozen. Cells were thawed at room temperature and resuspended in 15 ml of washing buffer (20 mM imidazole; 0.5 M NaCl; 20 mM Tris-HCl (pH 7.9); protease inhibitor cocktail (PIC) (Amersham Biosciences); and 1% Triton X-100). Cells were sonicated on ice and then spun at 50,000 rpm for 1 h at 4 °C. Supernatants were collected and poured over a 2.5-ml nickel-nitrilotriacetic acid-agarose (Qiagen) column, pre-washed twice with 20 ml of washing buffer. The resin was washed four times with 20 ml of washing buffer and then eluted with 4 ml of elution buffer (1 M imidazole, 0.5 M NaCl, and 20 mM Tris-HCl (pH 7.9)). The eluent was dialyzed into 40% glycerol/PBS with 1 mM beta -mercaptoethanol and 20 mM phenylmethylsulfonyl fluoride. His-DIC-1A was approximately 60% pure as determined by SDS-PAGE/Coomassie, and calculations of concentrations used were based on that purity.

Expression and Purification of MPB-RACK1-- A 10-ml LB/amp (100 µg/ml) overnight culture of BL21 cells containing pMAL-RACK1 was used to inoculate 500 ml of 2YT-amp (100 µg/ml). The culture was grown for 3 h (OD = 0.6) at 37 °C and then induced with IPTG (0.3 mM) for 3 h. Cells were collected and frozen. Cells were thawed at room temperature and resuspended in 15 ml of column buffer (10 mM Tris-HCl (pH 7.5), 200 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.5% Igepal, and protease inhibitor mixture). Cells were sonicated on ice and then spun at 35,000 rpm for 1 h at 4 °C. Supernatants were collected and poured over a 2.0-ml amylose resin (New England Biolabs) column, which had been pre-washed twice with 20 ml of column buffer. Resin was washed four times with 20 ml of column buffer, then eluted with 4 ml of elution buffer (column buffer and 10 mM maltose), and then dialyzed into 40% glycerol/column buffer. MBP-RACK1 was >85% pure as determined by SDS-PAGE/Coomassie.

Expression and Purification of Dynamin-1-- Expression and purification were carried out as described (60). Dynamin-1 was stored in GTPase buffer (50 mM Na-HEPES (pH 7.2), 10 mM MgSO4, 1 mM EDTA, 1 mM dithiothreitol, 0.1% Tween, 0.1 mg/ml bovine serum albumin). Dynamin-1 was >95% pure.

Immunoprecipitation with Recombinant and Purified Proteins-- Proteins were incubated at 4 °C with constant shaking for 30 min in a final volume of 200 µl using PBS for DIC/Gbeta gamma and column buffer for MBP-RACK1/Gbeta gamma . 1 µg of antibody (Santa Cruz) was added and incubated at 4 °C for 30 min, followed by the addition of 50 µl of a 50% slurry of protein A-Sepharose (Amersham Biosciences) and incubated at 4 °C for 30 min. The beads were washed three times with 500 µl of either PBS + 0.1% Igepal or column buffer + 0.1% Igepal, transferred to new tubes on the third wash, boiled in loading buffer, and resolved with SDS-PAGE (10-20%).

Immunoprecipitation with Endogenous Proteins-- NIH3T3 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, ampicillin (100 µg/ml), and streptomycin (100 µg/ml). When stated, cells were serum-starved for 6 h. A 100-mm plate of cells at ~85% confluency was lysed with 1.5 ml of RIPA buffer (100 mM Tris-HCl (pH 7.5), 1% Igepal, 0.5% deoxycholate, 0.1% SDS, and protease inhibitor mixture) or with Triton buffer (100 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1% Triton X-100, and PIC) at 4 °C with constant rotation for 30 min. Plates were scraped, and lysates were collected and centrifuged at 14,000 rpm for 45 min at 4 °C. The supernatants were collected and incubated with 2 µg of anti-Gbeta antibody overnight at 4 °C with constant shaking. The supernatants were incubated with 40 µl of a 50% slurry of protein A-Sepharose for 1 h at 4 °C with constant shaking. The resin was washed three times with buffer, transferred to new tubes on the third wash, boiled in loading buffer, and resolved with SDS-PAGE (10-20). The Triton-insoluble pellet was resuspended in 100 µl of PBS with 1% SDS and sonicated to disrupt it. 10 µl was added to each lane.

Western Blot-- The gels were transferred to polyvinylidene difluoride membranes using a semi-dry apparatus. The membranes were blocked with a 3% milk, PBS, 1% Igepal buffer for 30 min at 4 °C, followed by an overnight incubation with the appropriate antibody (DIC-1A (1:1000) (gift from Prof. Kevin Vaughn, University of Notre Dame); RACK1 (1:5000) and dynamin-1 (1:2000) (Transduction Laboratories); Gbeta (1:10,000) (Santa Cruz Biotechnology); Galpha t (1:10,000) (gift from Prof. David Manning, University of Pennsylvania); beta IIPKC (1:2000) (Santa Cruz Biotechnology)). The appropriate secondary antibody, conjugated to horseradish peroxidase, was incubated with the membrane for 1 h at room temperature. Detection was performed with chemiluminescence (Kirkegaard & Perry Laboratories or Pierce) by either x-ray film or a Fluor-S Imager (Bio-Rad).

GST-RACK1 Mutations-- The mutations N1 (RACK1 amino acids 1-203), C1 (amino acids 203-317), N2 (amino acids 1-111), and C2 (amino acids 113-207) were created using standard molecular cloning techniques. For N1 and C2, we made use of an internal BamHI site of RACK1. The full-length RACK1 in pGEX-4T (Amersham Biosciences) was cut with BamHI (there is a BamHI site in the multiple cloning site of pGEX-4T), which gives a C-terminal fragment, that was ligated into cut pGEX-4T and a pGEX-4-N-terminal RACK1 fragment that was ligated back together. For the N2 and C2 mutants, an EcoRI site was incorporated into pGEX-4T-N1-RACK1 using Quick Change site-directed mutagenesis, which changed alanine 112 to a glutamine. This construct was cut with EcoRI, which gives a C2 fragment and pGEX-4-N2-RACK1 fragment because of an EcoRI site in the multiple cloning site. The N2 fragment was ligated back onto itself, which subsequently incorporates an extra nine amino acids at the C terminus from the other restriction sites in the multiple cloning site. The C2 fragment was ligated into EcoRI-digested pGEX-4T. The correct clones were confirmed by sequencing.

GST-RACK1 and Mutant Expression-- 10 ml of BL21 cells containing pGEX4T-RACK1 or one of the mutants were grown overnight in LB/amp (100 µg/ml) at 37 °C with shaking. 500 ml of LB/amp was inoculated with the overnight sample, grown at 37 °C for 4 h (A600 = 1-1.3), and then induced with 0.2 mM IPTG for 3 h. Cells were collected by centrifugation at 2000 rpm for 10 min at 4 °C and washed once with PBS. The cells were frozen overnight at -80 °C. The cells were thawed on ice and resuspended in 15 ml of PBS, 1% Triton, 1 unit of PIC, sonicated, rotated for 1 h at 4 °C, and then centrifuged at 50,000 rpm for 1 h at 4 °C. Glycerol (50%) was added to the Triton-soluble fraction (supernatant), and the lysates were stored at -20 °C.

GST Binding Assays-- 0.5 ml of assay buffer (50 mM Tris-HCl (pH 7.4), 200 mM NaCl, 12 mM beta -mercaptoethanol, and 1% polyethylene glycol) with 1 unit of PIC was added to the glycerol lysate volume to yield a final concentration of 300 nM GST-RACK in the 200-µl assay (protein concentration was determined by isolating all the GST-RACK1 or mutant from a 1-ml aliquot of the glycerol lysates and using a Bradford protein assay). Glutathione-Sepharose (Amersham Biosciences), 50 µl of a 50% slurry, was added to the diluted lysate. The mixture was incubated for 30 min at room temperature with rotation. The resin was washed three times with 500 µl of assay buffer. The appropriate amount of G protein was added, and assay buffer was added to a final volume of 200 µl. This was incubated for 30 min at room temperature, washed three times with assay buffer, transferred to new tubes on the third wash, boiled in loading buffer, and resolved with SDS-PAGE. Studies with beta IIPKC included an extra incubation for 30 min at room temperature with activated beta IIPKC before G protein was added (beta IIPKC was activated by incorporating phospholipid vesicles, consisting of diacylglycerol (2 µg/ml) and phosphatidylserine (60 µg/ml), to the assay, then beta IIPKC (50 nM), and then 1 mM CaCl2 as described (39)). Studies with dynamin-1 included an extra incubation of 30 min at room temperature after the addition of G protein.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Yeast Two-hybrid Screen-- Bovine Gbeta 1, fused to the C terminus of the LexA binding domain (BD), was used as bait in a yeast two-hybrid screen of a mouse brain library. The library consisted of open reading frames ~1 kbp in length that were amplified from the poly(A) tail and fused to the C terminus of a yeast activation domain (AD). Prior to the screen, we determined that neither LexA-Gbeta 1 without the activating domain nor LexA-Gbeta 1 with the activation domain alone gave a positive result in the assay.

Because Gbeta 1 is normally associated with a Ggamma subunit, it was important to determine whether LexA-Gbeta 1 folds properly with endogenous yeast Ggamma . When properly folded and exposed to trypsin, Gbeta has only one exposed cleavage site (61). A tryptic digest of yeast lysates expressing LexA-Gbeta 1 found that most of the LexA-Gbeta 1 is folded properly, suggesting assembly with yeast Ggamma ; however, there was also some misfolded LexA-Gbeta 1 protein (not shown). Therefore, we repeated the yeast two-hybrid assay with our positive clones in the presence of bovine Ggamma 2 expressed from another yeast plasmid, pHyb. Under these conditions, all of the LexA-Gbeta 1 had only one tryptic cleavage site, indicating proper assembly with bovine Ggamma 2. Those clones that were positive when Ggamma 2 was present were further characterized.

To eliminate further false positives in the assay, we 1) confirmed the interaction of the isolated AD proteins with LexA-Gbeta 1; 2) determined if the isolated AD protein plus the BD alone was positive; and 3) determined if the AD protein alone gives a positive result. Unexpectedly, yeast with the AD protein and the LexA-BD alone grew on the leucine minus media; however, they did not turn blue, suggesting the promoter for LEU2 may be leaky. Table I outlines these results for the proteins presented here.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Yeast two-hybrid result

WD Repeat Protein-- The three clones in Table I are all WD40 repeat proteins: RACK1, DIC, and an unknown protein (AD2-61-1). The unknown protein matches the sequence of a hypothetical protein with the GenBankTM accession number AAH20044 but has no known function. All of the proteins fall into the same family as Gbeta and are thought to exhibit the same beta -propeller fold as Gbeta (Fig. 1A). When aligned according to their predicted WD motifs (Fig. 1B), the individual blades and the proteins show little sequence homology, except at key positions (highlighted in blue) as is usually seen for WD repeat proteins. Isolating three structurally similar proteins from a screen suggests the possibility that select WD repeat proteins may interact with each other.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 1.   Structure and sequence alignment of the WD repeat proteins. A, ribbon representation of the Gbeta 1gamma 1 crystal structure (18) (PDB1TBG). Ggamma 1, represented in blue, forms a coiled-coil interaction with the N terminus of Gbeta 1. The seven beta -blades of Gbeta 1, defined by a WD repeat, are highlighted in different colors. B, the sequences for Gbeta 1 (bovine) (RGB0B1), RACK1 (rat) (A36986), DIC-1A (mouse) (AAC33444), and the unknown protein (mouse) are shown. They were submitted to bmerc-www.bu.edu/bioinformatics/wdrepeat.html for analysis to predict WD repeat beta -blade formations. The sequences are aligned according to the WD repeat template (top of each blade alignment). Highlighted in blue are the amino acids important for hydrogen bonding and for stabilizing the toroidal structure, with the aspartic acid (italicized) being the most conserved residue (18). Arrows above the template represent which amino acids form the 4 beta -sheets, which in turn form each beta -blade. The red arrow indicates the first beta -sheet of the next blade. This is at the end of the variable loop region, which is in between each beta -blade. DIC has only six WD repeats; therefore its WD7 is its C terminus.

Immunoprecipitations-- We confirmed the interaction of Gbeta gamma with the DIC through co-immunoprecipitations (co-IP) (Fig. 2). A bacterially expressed human His-DIC-1A and bovine retinal Gbeta 1gamma 1 are shown to interact in vitro (Fig. 2A). This interaction is further verified by showing that endogenous DIC co-immunoprecipitates with a Gbeta antibody from NIH3T3 cells both in the presence and absence of serum (Fig. 2B, lanes 2 and 3, respectively).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Dynein intermediate chain co-immunoprecipitates with Gbeta gamma . A, in vitro immunoprecipitates (IP) of recombinant His-DIC1A (1 µM) and bovine Gbeta 1gamma 1 (1 µM). Lanes 1 and 2, IP using an anti-Gbeta 1 antibody (T20); lane 3, IP with no antibody. B, IP of endogenous DIC from NIH3T3 cells using an anti-Gbeta antibody (T20). Lane 1, control, no antibody; lane 2, IP from cells in serum; lane 3, IP from serum-starved cells (no fetal bovine serum); lane 4, RIPA-soluble fraction from cells with serum; lane 5, RIPA-soluble fraction from serum-starved cells. All experiments were repeated three times, unless otherwise noted.

We also confirmed the interaction of Gbeta gamma with RACK1 through co-IPs (Fig. 3). A bacterially expressed rat RACK1 fused to the maltose-binding protein (MBP) and bovine retinal Gbeta 1gamma 1 are shown to interact in vitro (Fig. 3A) using two different Gbeta antibodies (lanes 2 and 3) and a Ggamma 1 antibody (lane 4). Again, the interaction is further verified by showing that endogenous RACK1 co-IPs with a Gbeta 1 antibody (T20) from NIH3T3 cells both in the presence and absence of serum (Fig. 3B, lanes 3 and 4).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   RACK1 co-immunoprecipitates with Gbeta gamma . A, in vitro immunoprecipitates (IP) of recombinant MBP-RACK1 (1 µM) and bovine Gbeta 1gamma 1 (1 µM). Lane 1, purified MBP-RACK1 (1 µg); lanes 2 and 3, IP using two anti-Gbeta 1 antibodies T20 (C terminus directed antibody) and M14 (N terminus directed antibody); lane 4, IP using an anti-Ggamma 1 antibody; lane 5, control, no antibody. B, IP of endogenous RACK1 from NIH3T3 cells using an anti-Gbeta antibody (T20). Lane 1, purified MBP-RACK1 (0.5 µg); lane 2, control (no Gbeta 1gamma 1); lane 3, IP from cells in serum; lane 4, IP from serum-starved cells; lanes 5 and 6, Triton-soluble and -insoluble fractions from cells with serum; lanes 7 and 8, Triton-soluble and -insoluble fractions from serum-starved cells.

RACK1 Binds to Both Gbeta 1gamma 1 and Galpha tbeta 1gamma 1-- Investigation using a GST-RACK1 fusion protein revealed that not only does Gbeta 1gamma 1 interact with RACK1 but that heterotrimeric Galpha tbeta 1gamma 1 interacts with it and with an apparent higher affinity (Fig. 4A, compare lanes 3 and 5 to 4 and 6). Equal amounts of GST-RACK1 were loaded in each lane (Fig. 4A, top blot), demonstrating that the difference in affinity is not due to unequal amounts of RACK1. Again, as shown in Fig. 4B, Galpha tbeta 1gamma 1 has a higher affinity than Gbeta 1gamma 1 for RACK1 (compare lanes 4 to 5); however, neither Galpha t-GDP (lanes 6 and 7) nor Galpha t-GTP-gamma -S (lane 8) interacts with RACK1. Furthermore, because Galpha t is present (middle blot, lane 4) in the pull-down assay, RACK1 must interact with the heterotrimer and not just displace Galpha t while binding to Gbeta 1gamma 1. The interaction thus likely occurs through Gbeta 1gamma 1; however, Galpha t must contribute directly or indirectly to the interaction, because the heterotrimer has a higher affinity.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   GST-RACK1 binds purified Gbeta 1gamma 1 and Galpha tbeta 1gamma 1 but not Galpha t alone. A, RACK1 interacts with both Gbeta 1gamma 1 and Galpha tbeta 1gamma 1. Lanes 1 and 2 (control), GST alone with Gbeta 1gamma 1 and Galpha tbeta 1gamma 1; lanes 3 and 5, GST-RACK1 with Gbeta 1gamma 1, 0.5 and 1.0 µM; lanes 4 and 6, GST-RACK1 with Galpha tbeta 1gamma 1, 0.5 and 1.0 µM. The final concentration of GST and GST-RACK1 is estimated at 0.3 µM. Experiments were repeated five times. B, RACK1 does not interact with Galpha t-GDP or Galpha t-GTP-gamma -S. Lane 1, purified Galpha tbeta 1gamma 1; lanes 2 and 3 (control), GST alone with Gbeta 1gamma 1 and Galpha tbeta 1gamma 1; lane 4, GST-RACK1 with Galpha tbeta 1gamma 1, 1.0 µM; lane 5, GST-RACK1 with Gbeta 1gamma 1, 1.0 µM; lanes 6 and 7, GST-RACK1 with Galpha t-GDP, 0.5 and 1.0 µM; lane 8, GST-RACK1 with Galpha t-GTPgamma S, 1.0 µM. The final concentration of GST and GST-RACK1 is estimated at 0.3 µM. C, graph and blot depicting increasing amounts of Galpha tbeta 1gamma 1 and Gbeta 1gamma 1 bound to a fixed amount of GST-RACK1. GST-RACK1 (0.3 µM) was incubated with increasing amounts Gbeta 1gamma 1 or Galpha tbeta 1gamma 1. Lanes 1-5 and 6-10 are Galpha tbeta 1gamma 1 and Gbeta 1gamma 1, respectively, at concentrations of 0.1, 0.2, 0.4, 0.8, and 1.0 µM. The densitometry measurements (using Scion Image) are plotted as a percentage of maximum bound, with the maximum bound being the measurement at 1.0 µM and normalized to 100%. The measurements are graphed with GraphPad Prism software and using the equation parameters for a sigmoidal dose-response curve (variable slope) with an n = 2.

Apparent EC50 values of Galpha tbeta 1gamma 1 and Gbeta 1gamma 1 for GST-RACK1 were determined by binding increasing amounts of each protein to a fixed amount of GST-RACK1 (Fig. 4C, blot). The amount of Galpha tbeta 1gamma 1 or Gbeta 1gamma 1 pulled down was measured by densitometry and plotted as a percentage of maximum bound versus concentration (Fig. 4C, graph). As seen in the graph, 50% of Galpha tbeta 1gamma 1 binds at a concentration of 0.1 µM, whereas 50% of Gbeta 1gamma 1 binds at a concentration of 0.3 µM.

G Proteins Compete with Activated beta IIPKC for Binding to RACK1-- RACK1 was originally isolated by its ability to interact with activated beta IIPKC (62). We wanted to determine whether Galpha tbeta 1gamma 1 or Gbeta 1gamma 1 binds to RACK1 concurrently or competitively with activated beta IIPKC. Fig. 5A demonstrates that increasing the concentration of Gbeta 1gamma 1, either as heterodimer or as heterotrimer, decreases the amount of activated beta IIPKC bound to GST-RACK1 and increases the amount of Gbeta 1gamma 1 bound (compare lanes 1 to 2 for Gbeta 1gamma 1 and lanes 3 and 4 for Galpha tbeta 1gamma 1). Because there was a reduction of beta IIPKC and an increase in Gbeta 1gamma 1, the binding seemed to be competitive. However, higher concentrations of Gbeta 1gamma 1 (1 µM) never completely inhibited the binding of beta IIPKC to GST-RACK1 (not shown).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Galpha tbeta 1gamma 1 and Gbeta 1gamma 1 compete with activated beta IIPKC for binding to RACK1. A fixed amount of GST-RACK1 (0.3 µM) was incubated with a fixed amount of activated beta IIPKC (0.05 µM), followed by increasing amounts of Gbeta 1gamma 1 or Galpha tbeta 1gamma 1. Lanes 1 and 2 are 0.1 and 0.4 µM Gbeta 1gamma 1; and lanes 3 and 4 are 0.1 and 0.4 µM Galpha tbeta 1gamma 1. As more G protein is added, there is an increase in Gbeta 1gamma 1 binding and a decrease in activated beta IIPKC binding to RACK1.

Because the interaction seemed to be competitive but not mutually exclusive, we wanted to narrow down the site on RACK1 that interacts with Gbeta gamma . We constructed N-terminal (N1) and C-terminal (C1) mutants of RACK1 expressed as GST fusion proteins (Fig. 6A). Analysis of these two mutants (Fig. 6B) shows that G proteins interact with N1-RACK1 (lanes 6 and 7) and not with C1-RACK1 (lanes 8 and 9). To further define the interaction region on N1-RACK1, we divided this segment into two halves (Fig. 6A). However, this failed to narrow down one specific Gbeta gamma -binding site, because both truncation mutants, N2-RACK1 and C2-RACK1, bind Galpha tbeta 1gamma 1 and Gbeta 1gamma 1 (Fig. 6B, lanes 10 and 11). This result suggests that Gbeta 1gamma 1 has multiple sites of interaction on RACK1, with probable overlap on one of the beta IIPKC-binding sites (63). This may explain why Gbeta 1gamma 1 competes with activated beta IIPKC but never fully inhibits its binding to RACK1.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 6.   Gbeta gamma has multiple binding sites on RACK1. A, diagram depicting GST-RACK1 and its mutations. The mutations are as follows: N1-RACK1, amino acids 1-207; C1-RACK1, 207-313; N2-RACK1, 1-111; and C2-RACK1, 113-207. The hatched areas are the points of interaction with beta IIPKC. B, to determine which mutants bind G proteins, GST-RACK1 or its mutants were incubated with Galpha tbeta 1gamma 1 or Gbeta 1gamma 1, upper panel and lower panel, respectively. Lanes 2-9 have two concentrations of Galpha tbeta 1gamma 1, 0.5 and 1.0 µM, or of Gbeta 1gamma 1, 1.0 and 2.0 µM. Lane 1, purified G protein; lanes 2 and 3, control using GST; lanes 4 and 5, GST-RACK1 (0.25 µM); lanes 6 and 7, GST-N1-RACK1 (0.5 µM); lanes 8 and 9, GST-C1-RACK1 (0.5 µM). Lanes 10 and 11 are GST-N2-RACK1 (0.5 µM) and GST-C2-RACK1 (0.5 µM), respectively, with 0.5 µM Galpha tbeta 1gamma 1 or 1.0 µM Gbeta 1gamma 1.

Galpha tbeta 1gamma 1 and Gbeta 1gamma 1 Differ in Their Interaction with RACK1 When Dynamin-1 Is Present-- A second RACK1 interacting protein is dynamin-1 (40), which also interacts with Gbeta gamma (11, 55). We wanted to determine whether Galpha tbeta 1gamma 1 or Gbeta 1gamma 1 bind to RACK1 concurrently or competitively with dynamin-1. Keeping GST-RACK1 and Gbeta 1gamma 1 or Galpha tbeta 1gamma 1 constant, while increasing the concentration of dynamin-1 (Fig. 7), showed distinctively different results between Galpha tbeta 1gamma 1 (lanes 2-6) and Gbeta 1gamma 1 (lanes 7-11). For Galpha tbeta 1gamma 1, dynamin-1 excluded it from GST-RACK1 but not until its highest concentration (lane 6), demonstrating competition. For Gbeta 1gamma 1, the lowest concentration of dynamin-1 excluded it from GST-RACK1 (lane 8). Interestingly, very little dynamin-1 bound to GST-RACK1 at its lower concentrations (lanes 8 and 9); however, there is dynamin-1 bound at its higher concentrations (lanes 10 and 11). This also demonstrates competition, but the dynamics of the interaction are more complex because Gbeta 1gamma 1 also interacts with dynamin-1 (11, 55). A probable explanation for these results is that all of the proteins compete for binding to each other but that the affinity of Gbeta 1gamma 1 and dynamin-1 is higher than that of RACK1 for either protein. At the lower concentrations of dynamin-1, it was all bound to the Gbeta 1gamma 1, preventing it or Gbeta 1gamma 1 from binding to GST-RACK1. At the higher concentrations of dynamin-1, there was an excess of protein that was not bound to Gbeta 1gamma 1 and so in turn bound GST-RACK1.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 7.   RACK1, G proteins, and dynamin-1 do not bind concurrently. To determine whether there is competition with dynamin-1, a fixed amount of GST-RACK1 (0.3 µM) was incubated with a fixed amount of Galpha tbeta 1gamma 1 (0.2 µM), lanes 2-6, or Gbeta 1gamma 1 (0.4 µM), lanes 7-11, followed by incubation with increasing amounts of dynamin-1 (0, 0.125, 0.25, 0.5, and 1.0 µM), lanes 2-6 and 7-11. Lane 1 is purified dynamin-1 (1.0 µM) and Galpha tbeta 1gamma 1 (0.2 µM). The binding of Galpha tbeta 1gamma 1 to RACK1 was not inhibited until the highest concentration of dynamin-1, whereas the binding of Gbeta 1gamma 1 was inhibited at the lowest concentration of dynamin-1. Experiments were repeated four times.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

WD Repeat Motif-- A recurrent theme in signaling processes has emerged, that of multimeric protein complexes with activators and effectors bound together by adaptors in precise spatial arrangement to ensure proper cellular signaling. The association of multiple WD repeat proteins with Gbeta gamma from a yeast two-hybrid screen suggests a new interaction motif. One could easily imagine WD repeat proteins as the scaffold for such a multimeric protein complex. Gbeta was the first WD repeat protein crystallized, and because the WD repeat is a structural element for the beta -propeller, all WD repeat proteins are thought to exhibit the same toroidal shape as Gbeta (Fig. 1A) with variations on the number of repeats (16, 17). When trying to visualize the interaction of two WD repeat proteins with each other, it would be interesting to consider if it occurs top-to-bottom, side-to-side, side-to-top, or side-to-bottom. Structural studies of WD repeat protein complexes would help us understand the basis of their interaction.

Interaction between Gbeta gamma and DIC-- The evidence presented for this interaction consists of a yeast two-hybrid interaction and co-IPs. Any discussion of its function must be based on the known literature. Furthermore, the interaction (Fig. 2) is weak when compared with the interaction of Gbeta gamma with RACK1 (Fig. 3) and may not be absolute. However, there may be binding cofactors that facilitate the interaction, i.e. when DIC is in complex with its light and heavy chains. This has precedent in the interaction of Gbeta gamma with the exocytotic machinery; Gbeta gamma has a higher affinity for the complex than the individual components (64).

Several interesting findings stand out in the literature that could lead to possible functional roles of the Gbeta gamma and DIC interaction. One is the finding that tctex-1, a dynein light chain, interacts with the C terminus of rhodopsin, a GPCR (27, 65), which is shown to be important for apical transport. The light chains of dynein interact directly with the intermediate chains (23), which raises the question: do G proteins help regulate apical transport through the interaction of Gbeta gamma with DIC? Another scenario could have G proteins helping to define the intracellular role of dynein by regulating its interaction with dynactin (28, 31, 32). This interaction is regulated by phosphorylation (34, 35); however, it has not been clearly defined (24). Could G proteins help provide specificity for the involvement of dynein in cell division and/or intracellular transport, cellular processes that also involve heterotrimeric G proteins (14, 15, 66-68)? The literature poses several other avenues that could be pursued, and it will be interesting to discern the functional role(s) of this interaction.

Interaction between Gbeta gamma and RACK1-- At first, our interest in this interaction was initiated by a possible connection to undefined Gbeta gamma -mediated responses. RACK1 interacts with both activated beta IIPKC (37) and dynamin-1 (40), two proteins that are also linked to heterotrimeric G proteins. beta IIPKC is a serine/threonine kinase activated downstream of phospholipase C (69) and subsequently heterotrimeric G proteins (70). PKCs are important second messengers (71) with many substrates, among which are the Galpha subunits i, z, 12, and 16 (51-54). Phosphorylation of the N terminus of Galpha prevents its re-association with the Gbeta gamma subunit, possibly prolonging signaling through both subunits. Dynamin-1 is a large GTPase involved in clathrin-coated receptor endocytosis (72) and more recently has been linked to the MAP kinase pathway (73). Interestingly, RACK1 and Gbeta gamma have opposite effects on dynamin-1: Gbeta gamma inhibits its GTPase activity (55), and RACK1 increases it (40). These literature findings suggest that there may be a dynamic interaction between these proteins leading to an intracellular response such as signal attenuation, MAP kinase activation, and/or receptor endocytosis.

The interaction of RACK1 with Gbeta gamma was confirmed through co-IPs (Fig. 3). Subsequent studies using GST-RACK1 shows that it not only interacts with Gbeta 1gamma 1 alone but also in the heterotrimeric form, Galpha tbeta 1gamma 1, and with an apparent higher affinity (Fig. 4). This was very surprising for the following two reasons: 1) very few proteins, other than receptors, interact with the whole heterotrimer (2); and 2) all known Gbeta gamma effectors bind to its Galpha -interacting face (57, 58). RACK1 does not interact with Galpha t alone; however, the Galpha subunit must contribute to the interaction because the heterotrimer has a 3-fold higher affinity than the heterodimer for RACK1 (compare EC50, Fig. 4C). Galpha t could stabilize a conformation of Gbeta 1gamma 1 that binds better to RACK1 or Galpha t could participate in the interaction but not with high enough affinity that it can bind RACK1 alone. Structural studies are needed to determine the involvement of Galpha t in the interaction.

To discern a function of this interaction, we first explored the involvement of activated beta IIPKC (Fig. 5). Both Gbeta 1gamma 1 and Galpha tbeta 1gamma 1 compete with the binding of activated beta IIPKC to GST-RACK1 but do not entirely block the interaction. Mutational analysis of RACK1 (Fig. 6) suggests that Gbeta 1gamma 1 has multiple RACK1-binding sites, with probable overlap on one of the beta IIPKC-binding sites. This could cause competition with beta IIPKC binding to RACK1 but not full exclusion.

Extending our studies to dynamin-1 (Fig. 7), we found that it competes with the binding of Galpha tbeta 1gamma 1 to RACK1 but not until its highest concentration (1 µM). There is also a competition between dynamin-1, RACK1, and Gbeta 1gamma 1; however, it is more dynamic because all three proteins can interact with each other. Dynamin-1 competes with the binding of RACK1 to Gbeta 1gamma 1 in a way that suggests the affinity of Gbeta 1gamma 1 and dynamin-1 is higher than that of RACK1 and dynamin-1 or that of RACK1 and Gbeta 1gamma 1.

Implications for G Protein Signaling-- The importance of the interaction of Gbeta gamma with RACK1 still remains to be determined; however, one interesting scenario concerns the localization of RACK1 to the membrane. RACK1 is found associated with the plasma membrane (1), yet it is not known to be post-translationally modified in any way that would promote membrane association, and it is not known to interact with a Ggamma -like domain-containing protein to localize it to the membrane, such as Gbeta (19). Interestingly, Sondek and Siderovski (19) propose that RACK1 interacts with PDE4D5 through a Ggamma -like domain. Could the interaction of RACK1 with Gbeta gamma be its mechanism of recruitment and association with the membrane, reminiscent of Gbeta gamma and GRK2 (7)? One could imagine a Gbeta gamma -localized, membrane-associated RACK1, which after stimulation of a Galpha q-coupled receptor and subsequent activation of PKC, would be in a position to help recruit activated PKC to the membrane (36). PKC would then be able to phosphorylate its desired substrates at the membrane, which include various Galpha subunits (51-54).

Another approach to elucidate a role for this interaction is to determine the effect RACK1 has on heterotrimeric G proteins. The surprising result that RACK1 interacts with the Galpha tbeta 1gamma 1 heterotrimer as well as with the Gbeta 1gamma 1 heterodimer raises several questions. First, is the interaction of RACK1 with heterotrimeric G proteins subunit-specific? Second, is the increase in affinity of RACK1 for heterotrimer over heterodimer seen with other subunits? Finally, because RACK1 interacts with the heterotrimer, does it affect signaling from a GPCR? Preliminary experiments have shown that RACK1 does bind to Gbeta 1gamma 2, with a similar affinity as Gbeta 1gamma 1. RACK1 also seems to interact with other heterotrimers2; further studies will verify these interactions and quantify their affinities for RACK1.

There still remain other questions that can be asked for defining the functionality of this interaction. What is the importance of the interplay with dynamin-1? Is there a connection to Src or beta  integrin signaling in that both G proteins (9, 10, 56) and RACK1 (41-44) are involved in the regulation of Src-mediated and integrin-mediated signaling? The interaction between these two proteins has initiated more questions than it has resolved. Nonetheless, these initial studies have provided us with a solid foundation that could lead us to further insight into the dynamics of cellular signaling.

    FOOTNOTES

* This work was supported by Grant EY100291 from the National Institutes of Health (to H. E. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed. Tel.: 615-343-3533; Fax: 615-343-1084; E-mail: heidi.hamm@vanderbilt.edu.

Published, JBC Papers in Press, September 30, 2002, DOI 10.1074/jbc.M202755200

2 S. Chen, E. J. Dell, and H. E. Hamm, unpublished data.

    ABBREVIATIONS

The abbreviations used are: GPCR, G protein-coupled receptor; MAP, mitogen-activated protein; co-ip, co-immunoprecipitations; DIC, dynein intermediate chain; RACKs, receptor for activated C kinases; PKC, protein kinase C; X-gal, 5-bromo-4-chloro-3-indolyl beta -D-galactopyranoside; BD, binding domain; AD, activation domain; IPTG, isopropylthio-beta -galactoside; PBS, phosphate-buffered saline; MBP, maltose-binding protein; GST, glutathione S-transferase; GTPgamma S, guanosine 5'-3-O-(thio)triphosphate; IP, immunoprecipitates.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Schechtman, D., and Mochly-Rosen, D. (2001) Oncogene 20, 6339-6347